These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 9191841
1. Changes in the dengue virus major envelope protein on passaging and their localization on the three-dimensional structure of the protein. Lee E, Weir RC, Dalgarno L. Virology; 1997 Jun 09; 232(2):281-90. PubMed ID: 9191841 [Abstract] [Full Text] [Related]
2. Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Guirakhoo F, Hunt AR, Lewis JG, Roehrig JT. Virology; 1993 May 09; 194(1):219-23. PubMed ID: 8480420 [Abstract] [Full Text] [Related]
3. Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus. Duarte dos Santos CN, Frenkiel MP, Courageot MP, Rocha CF, Vazeille-Falcoz MC, Wien MW, Rey FA, Deubel V, Desprès P. Virology; 2000 Sep 01; 274(2):292-308. PubMed ID: 10964773 [Abstract] [Full Text] [Related]
4. Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation. Mondotte JA, Lozach PY, Amara A, Gamarnik AV. J Virol; 2007 Jul 01; 81(13):7136-48. PubMed ID: 17459925 [Abstract] [Full Text] [Related]
6. Domain-III FG loop of the dengue virus type 2 envelope protein is important for infection of mammalian cells and Aedes aegypti mosquitoes. Erb SM, Butrapet S, Moss KJ, Luy BE, Childers T, Calvert AE, Silengo SJ, Roehrig JT, Huang CY, Blair CD. Virology; 2010 Oct 25; 406(2):328-35. PubMed ID: 20708768 [Abstract] [Full Text] [Related]
7. Common E protein determinants for attenuation of glycosaminoglycan-binding variants of Japanese encephalitis and West Nile viruses. Lee E, Hall RA, Lobigs M. J Virol; 2004 Aug 25; 78(15):8271-80. PubMed ID: 15254199 [Abstract] [Full Text] [Related]
8. The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Johnson AJ, Guirakhoo F, Roehrig JT. Virology; 1994 Sep 25; 203(2):241-9. PubMed ID: 8053148 [Abstract] [Full Text] [Related]
14. Dengue virus type 2 envelope protein displayed as recombinant phage attachment protein reveals potential cell binding sites. Abd-Jamil J, Cheah CY, AbuBakar S. Protein Eng Des Sel; 2008 Oct 25; 21(10):605-11. PubMed ID: 18669522 [Abstract] [Full Text] [Related]
15. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus. Pletnev AG, Karganova GG, Dzhivanyan TI, Lashkevich VA, Bray M. Virology; 2000 Aug 15; 274(1):26-31. PubMed ID: 10936085 [Abstract] [Full Text] [Related]
16. Epitope determinants of a chimpanzee Fab antibody that efficiently cross-neutralizes dengue type 1 and type 2 viruses map to inside and in close proximity to fusion loop of the dengue type 2 virus envelope glycoprotein. Goncalvez AP, Purcell RH, Lai CJ. J Virol; 2004 Dec 15; 78(23):12919-28. PubMed ID: 15542644 [Abstract] [Full Text] [Related]
17. Glycosylation of the dengue 2 virus E protein at N67 is critical for virus growth in vitro but not for growth in intrathoracically inoculated Aedes aegypti mosquitoes. Bryant JE, Calvert AE, Mesesan K, Crabtree MB, Volpe KE, Silengo S, Kinney RM, Huang CY, Miller BR, Roehrig JT. Virology; 2007 Sep 30; 366(2):415-23. PubMed ID: 17543367 [Abstract] [Full Text] [Related]
18. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys. Guirakhoo F, Zhang Z, Myers G, Johnson BW, Pugachev K, Nichols R, Brown N, Levenbook I, Draper K, Cyrek S, Lang J, Fournier C, Barrere B, Delagrave S, Monath TP. J Virol; 2004 Sep 30; 78(18):9998-10008. PubMed ID: 15331733 [Abstract] [Full Text] [Related]